(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ARILSULFATASE A PURIFICADA E COMPOSIÇÕES DA MESMA

Em ExigênciaInvention PatentPCT · US2018066583

Application data

Number

112020012637

Type

Invention Patent

Filing

12/19/2018

Publication

12/01/2020

PCT

US2018066583

Progress at the INPI

Technical opinion to answer
  1. Filing12/19/18
  2. Publication12/01/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/01/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SHIRE HUMAN GENETIC THERAPIES, INC

US

TAKEDA PHARMACEUTICAL COMPANY LIMITED

JP

See this company's full portfolio

Inventors

A. K. (pessoa física)

US

G. E. (pessoa física)

US

Technical data

Priority claims

US

62/607,831 · 12/19/2017

US

62/608,569 · 12/20/2017

US

62/625,814 · 02/02/2018

US

62/760,597 · 11/13/2018

Abstract

A presente invenção fornece, entre outras coisas, métodos de tratamento da Doença de Leucodistrofia Metacromática (MLD) e composições compreendendo a proteína arilsulfatase A recombinante (ASA) usando terapia de reposição enzimática.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

04/01/2025

RPI 2830

Transferência deferida

#25.1

12/28/2021

RPI 2660

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

12/01/2020

RPI 2604

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.